-
我が国のワクチン発祥の地、
長崎から新たに始まるワクチン開発研究 -
-
Topics
新着情報
-
-
-
-
感染症疫学短期コース “Introduction to Infectious Disease Epidemiology and Modelling” を開催しました
Thursday 24 August 2023 -
-
-
-
-
感染症疫学短期コース “Introduction to Infectious Disease Epidemiology and Modelling” を開催しました
Thursday 24 August 2023
登録されている記事がありません。
About us
ワクチン研究開発拠点について
長崎大学感染症研究出島特区 ワクチン研究開発拠点は，「ワクチン開発のための世界トップレベル研究開発拠点の形成事業」に採択された4つのシナジー拠点の一つです。長崎大学がこれまで研究してきた高病原性病原体や熱帯性病原体を対象としたワクチン開発を推進し，人類の脅威となる感染症に対するワクチン開発を目指します。
Publications
研究業績
12924226
apa
5
desc
year
1
54
https://dida.nagasaki-u.ac.jp/dida_wp/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-87ab10cc5dd9239bc0a0c9241b4cd332%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22VG8TNDCH%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mogasale%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-28%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMogasale%2C%20V.%2C%20Sinha%2C%20A.%2C%20John%2C%20J.%2C%20Farooqui%2C%20H.%2C%20Ray%2C%20A.%2C%20Chantler%2C%20T.%2C%20Mogasale%2C%20V.%2C%20Dhoubhadel%2C%20B.%20G.%2C%20Edmunds%2C%20W.%20J.%2C%20Clark%2C%20A.%20D.%2C%20%26amp%3B%20Abbas%2C%20K.%20%282024%29.%20%3Ci%3ETyphoid%20Conjugate%20Vaccine%20Implementation%20in%20India%3A%20A%20Review%20of%20Supportive%20Evidence%3C%5C%2Fi%3E%20%28SSRN%20Scholarly%20Paper%20No.%204870785%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2139%5C%2Fssrn.4870785%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2139%5C%2Fssrn.4870785%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Typhoid%20Conjugate%20Vaccine%20Implementation%20in%20India%3A%20A%20Review%20of%20Supportive%20Evidence%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijayalaxmi%22%2C%22lastName%22%3A%22Mogasale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anish%22%2C%22lastName%22%3A%22Sinha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%22%2C%22lastName%22%3A%22John%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Habib%22%2C%22lastName%22%3A%22Farooqui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arindam%22%2C%22lastName%22%3A%22Ray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tracey%22%2C%22lastName%22%3A%22Chantler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vittal%22%2C%22lastName%22%3A%22Mogasale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bhim%20Gopal%22%2C%22lastName%22%3A%22Dhoubhadel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20John%22%2C%22lastName%22%3A%22Edmunds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Typhoid%20conjugate%20vaccines%20are%20available%20in%20the%20private%20market%20in%20India%20and%20are%20also%20recommended%20by%20the%20National%20Technical%20Advisory%20Group%20on%20Immunisation%20for%20inclusion%20in%20the%20Universal%20Immunisation%20Programme%20in%202022%20to%20control%20and%20prevent%20typhoid%20fever.%20The%20aim%20of%20our%20study%20is%20to%20synthesise%20the%20supportive%20evidence%20for%20typhoid%20conjugate%20vaccine%20implementation%20in%20India.%20Methods%3A%20We%20conducted%20a%20literature%20review%20to%20identify%20supportive%20evidence%20for%20typhoid%20conjugate%20vaccine%20implementation%20in%20India%20based%20on%20the%20key%20criteria%20of%20the%20Evidence-to-Recommendation%20framework%20developed%20by%20the%20World%20Health%20Organisation%20for%20National%20Immunisation%20Technical%20Advisory%20Groups.%20Results%3A%20We%20synthesised%20credible%20evidence%20on%20the%20burden%20of%20typhoid%20disease%2C%20the%20benefits%20and%20safety%20of%20typhoid%20conjugate%20vaccine%2C%20cost-effectiveness%20analysis%2C%20and%20implementation%20feasibility.%20However%2C%20the%20evidence%20on%20budget%20impact%20analysis%2C%20vaccine%20demand%20and%20supply%20forecast%2C%20equity%20analysis%2C%20target%20population%20values%20and%20preferences%2C%20acceptability%20of%20immunisation%20service%20providers%2C%20in-country%20data%20on%20co-administration%20safety%2C%20and%20antimicrobial%20resistance%20tracking%20was%20limited.%20Conclusion%3A%20We%20identified%20and%20listed%20evidence%20gaps%20based%20on%20the%20literature%20review.%20We%20recommend%20identifying%20research%20priorities%20for%20supporting%20typhoid%20conjugate%20vaccine%20decision-making%20in%20India%20by%20combining%20evidence%20gaps%20with%20the%20perceived%20importance%20of%20the%20same%20evidence%20among%20immunisation%20stakeholders.%20Further%2C%20we%20recognised%20a%20need%20for%20a%20bivalent%20enteric%20fever%20vaccine%20in%20India%20and%20a%20lack%20of%20evidence%20demonstrating%20the%20potential%20public%20health%20value%20of%20these%20new%20bivalent%20vaccines%20in%20the%20pipeline.%22%2C%22genre%22%3A%22SSRN%20Scholarly%20Paper%22%2C%22repository%22%3A%22%22%2C%22archiveID%22%3A%224870785%22%2C%22date%22%3A%222024-03-28%22%2C%22DOI%22%3A%2210.2139%5C%2Fssrn.4870785%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fpapers.ssrn.com%5C%2Fabstract%3D4870785%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-07-01T02%3A12%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22GBFAZAEK%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ondo%20et%20al.%22%2C%22parsedDate%22%3A%222024-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EOndo%2C%20G.%20N.%2C%20Ushijima%2C%20Y.%2C%20Abe%2C%20H.%2C%20Mahmoudou%2C%20S.%2C%20Bikangui%2C%20R.%2C%20Nkoma%2C%20A.%20M.%2C%20Mbadinga%2C%20M.%20J.%20V.%20M.%2C%20More%2C%20A.%2C%20Agbanrin%2C%20M.%20D.%2C%20Pemba%2C%20C.%20M.%2C%20Beh%20Mba%2C%20R.%2C%20Akim%2C%20A.%20A.%2C%20Lell%2C%20B.%2C%20%26amp%3B%20Yasuda%2C%20J.%20%282024%29.%20Genetic%20Diversity%20and%20Detection%20of%20Respiratory%20Viruses%20Excluding%20SARS-CoV-2%20during%20the%20COVID-19%20Pandemic%20in%20Gabon%2C%202020%26%23x2013%3B2021.%20%3Ci%3EViruses%3C%5C%2Fi%3E%2C%20%3Ci%3E16%3C%5C%2Fi%3E%285%29%2C%20698.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv16050698%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv16050698%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Genetic%20Diversity%20and%20Detection%20of%20Respiratory%20Viruses%20Excluding%20SARS-CoV-2%20during%20the%20COVID-19%20Pandemic%20in%20Gabon%2C%202020%5Cu20132021%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgelin%20Nguema%22%2C%22lastName%22%3A%22Ondo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuri%22%2C%22lastName%22%3A%22Ushijima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haruka%22%2C%22lastName%22%3A%22Abe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sa%5Cu00efdou%22%2C%22lastName%22%3A%22Mahmoudou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigue%22%2C%22lastName%22%3A%22Bikangui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20Marie%22%2C%22lastName%22%3A%22Nkoma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marien%20Juliet%20Veraldy%20Magossou%22%2C%22lastName%22%3A%22Mbadinga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayong%22%2C%22lastName%22%3A%22More%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maradona%20Daouda%22%2C%22lastName%22%3A%22Agbanrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christelle%20M.%22%2C%22lastName%22%3A%22Pemba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romuald%22%2C%22lastName%22%3A%22Beh%20Mba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adegnika%20Ayola%22%2C%22lastName%22%3A%22Akim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bertrand%22%2C%22lastName%22%3A%22Lell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiro%22%2C%22lastName%22%3A%22Yasuda%22%7D%5D%2C%22abstractNote%22%3A%22Acute%20respiratory%20infections%20are%20a%20major%20global%20burden%20in%20resource-limited%20countries%2C%20including%20countries%20in%20Africa.%20Although%20COVID-19%20has%20been%20well%20studied%20since%20the%20pandemic%20emerged%20in%20Gabon%2C%20Central%20Africa%2C%20less%20attention%20has%20been%20paid%20to%20other%20respiratory%20viral%20diseases%2C%20and%20very%20little%20data%20are%20available.%20Herein%2C%20we%20provide%20the%20first%20data%20on%20the%20genetic%20diversity%20and%20detection%20of%2018%20major%20respiratory%20viruses%20in%20Gabon%20during%20the%20COVID-19%20pandemic.%20Of%20582%20nasopharyngeal%20swab%20specimens%20collected%20from%20March%202020%20to%20July%202021%2C%20which%20were%20SARS-CoV-2%20negative%2C%20156%20were%20positive%20%2826%25%29%20for%20the%20following%20viruses%3A%20enterovirus%20%2820.3%25%29%2C%20human%20rhinovirus%20%28HRV%29%20%284.6%25%29%2C%20human%20coronavirus%20OC43%20%281.2%25%29%2C%20human%20adenovirus%20%280.9%25%29%2C%20human%20metapneumovirus%20%28hMPV%29%20%280.5%25%29%2C%20influenza%20A%20virus%20%28IAV%29%20%280.3%25%29%2C%20and%20human%20parainfluenza%20viruses%20%280.5%25%29.%20To%20determine%20the%20genetic%20diversity%20and%20transmission%20route%20of%20the%20viruses%2C%20phylogenetic%20analyses%20were%20performed%20using%20genome%20sequences%20of%20the%20detected%20viruses.%20The%20IAV%20strain%20detected%20in%20this%20study%20was%20genetically%20similar%20to%20strains%20isolated%20in%20the%20USA%2C%20whereas%20the%20hMPV%20strain%20belonging%20to%20the%20A2b%20subtype%20formed%20a%20cluster%20with%20Kenyan%20strains.%20This%20study%20provides%20the%20first%20complete%20genomic%20sequences%20of%20HRV%2C%20IAV%2C%20and%20hMPV%20detected%20in%20Gabon%2C%20and%20provides%20insight%20into%20the%20circulation%20of%20respiratory%20viruses%20in%20the%20country.%22%2C%22date%22%3A%222024%5C%2F5%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fv16050698%22%2C%22ISSN%22%3A%221999-4915%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F1999-4915%5C%2F16%5C%2F5%5C%2F698%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-06-17T05%3A49%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22QIAA2HTB%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Murayama%20et%20al.%22%2C%22parsedDate%22%3A%222023-12-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMurayama%2C%20H.%2C%20Endo%2C%20A.%2C%20%26amp%3B%20Yonekura%2C%20S.%20%282023%29.%20Estimation%20of%20waning%20vaccine%20effectiveness%20from%20population-level%20surveillance%20data%20in%20multi-variant%20epidemics.%20%3Ci%3EEpidemics%3C%5C%2Fi%3E%2C%20%3Ci%3E45%3C%5C%2Fi%3E%2C%20100726.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.epidem.2023.100726%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.epidem.2023.100726%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Estimation%20of%20waning%20vaccine%20effectiveness%20from%20population-level%20surveillance%20data%20in%20multi-variant%20epidemics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroaki%22%2C%22lastName%22%3A%22Murayama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akira%22%2C%22lastName%22%3A%22Endo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shouto%22%2C%22lastName%22%3A%22Yonekura%22%7D%5D%2C%22abstractNote%22%3A%22Monitoring%20time-varying%20vaccine%20effectiveness%20%28e.g.%2C%20due%20to%20waning%20of%20immunity%20and%20the%20emergence%20of%20novel%20variants%29%20provides%20crucial%20information%20for%20outbreak%20control.%20Existing%20studies%20of%20time-varying%20vaccine%20effectiveness%20have%20used%20individual-level%20data%2C%20most%20importantly%20dates%20of%20vaccination%20and%20variant%20classification%2C%20which%20are%20often%20not%20available%20in%20a%20timely%20manner%20or%20from%20a%20wide%20range%20of%20population%20groups.%20We%20present%20a%20novel%20Bayesian%20framework%20for%20estimating%20the%20waning%20of%20variant-specific%20vaccine%20effectiveness%20in%20the%20presence%20of%20multi-variant%20circulation%20from%20population-level%20surveillance%20data.%20Applications%20to%20simulated%20outbreaks%20and%20the%20COVID-19%20epidemic%20in%20Japan%20are%20also%20presented.%20Our%20results%20show%20that%20variant-specific%20waning%20vaccine%20effectiveness%20estimated%20from%20population-level%20surveillance%20data%20could%20approximately%20reproduce%20the%20estimates%20from%20previous%20test-negative%20design%20studies%2C%20allowing%20for%20rapid%2C%20if%20crude%2C%20assessment%20of%20the%20epidemic%20situation%20before%20fine-scale%20studies%20are%20made%20available.%22%2C%22date%22%3A%222023-12-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.epidem.2023.100726%22%2C%22ISSN%22%3A%221755-4365%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1755436523000622%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-06-17T05%3A48%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22K7AEAQAJ%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ngwe%20Tun%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENgwe%20Tun%2C%20M.%20M.%2C%20Luvai%2C%20E.%20A.%20C.%2C%20Toizumi%2C%20M.%2C%20Moriuchi%2C%20M.%2C%20Takamatsu%2C%20Y.%2C%20Inoue%2C%20S.%2C%20Urano%2C%20T.%2C%20Bui%2C%20M.%20X.%2C%20Thai%20Hung%2C%20D.%2C%20Thi%20Nguyen%2C%20H.-A.%2C%20Anh%2C%20D.%20D.%2C%20Yoshida%2C%20L.-M.%2C%20Moriuchi%2C%20H.%2C%20%26amp%3B%20Morita%2C%20K.%20%282024%29.%20Possible%20vertical%20transmission%20of%20Chikungunya%20virus%20infection%20detected%20in%20the%20cord%20blood%20samples%20from%20a%20birth%20cohort%20in%20Vietnam.%20%3Ci%3EJournal%20of%20Infection%20and%20Public%20Health%3C%5C%2Fi%3E%2C%20%3Ci%3E17%3C%5C%2Fi%3E%286%29%2C%201050%26%23x2013%3B1056.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jiph.2024.04.012%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jiph.2024.04.012%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Possible%20vertical%20transmission%20of%20Chikungunya%20virus%20infection%20detected%20in%20the%20cord%20blood%20samples%20from%20a%20birth%20cohort%20in%20Vietnam%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20Ajema%20Chebichi%22%2C%22lastName%22%3A%22Luvai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michiko%22%2C%22lastName%22%3A%22Toizumi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masako%22%2C%22lastName%22%3A%22Moriuchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shingo%22%2C%22lastName%22%3A%22Inoue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minh%20Xuan%22%2C%22lastName%22%3A%22Bui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Do%22%2C%22lastName%22%3A%22Thai%20Hung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hien-Anh%22%2C%22lastName%22%3A%22Thi%20Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dang%20Duc%22%2C%22lastName%22%3A%22Anh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lay-Myint%22%2C%22lastName%22%3A%22Yoshida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroyuki%22%2C%22lastName%22%3A%22Moriuchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnChikungunya%20virus%20%28CHIKV%29%20is%20an%20alphavirus%20%28genus%20Alphavirus%2C%20family%20Togaviridae%29%20that%20is%20primarily%20transmitted%20to%20humans%20by%20Aedes%20mosquitoes%2C%20and%20can%20be%20transmitted%20from%20mother%20to%20child.%20Little%20is%20known%20about%20CHIKV%20transmission%20in%20Vietnam%2C%20where%20dengue%20is%20endemic%20and%20Aedes%20mosquitoes%20are%20abundant.%20This%20study%20aimed%20to%20determine%20the%20prevalence%20and%20characteristics%20of%20vertical%20CHIKV%20infection%20in%20a%20birth%20cohort%2C%20and%20seroprevalence%20of%20anti-CHIKV%20antibodies%20with%20or%20without%20confirmation%20by%20neutralization%20tests%20among%20women%20bearing%20children%20in%20Vietnam.%5CnMethods%5CnWe%20collected%20umbilical%20cord%20blood%20plasma%20samples%20from%20each%20newly%20delivered%20baby%20in%20Nha%20Trang%2C%20Central%20Vietnam%2C%20between%20July%202017%20and%20September%202018.%20Samples%20were%20subjected%20to%20molecular%20assay%20%28quantitative%20real-time%20RT-PCR%29%20and%20serological%20tests%20%28anti-CHIKV%20IgM%20capture%20and%20IgG%20indirect%20enzyme-linked%20immunosorbent%20assay%2C%20and%20neutralization%20tests%29.%5CnResults%5CnOf%20the%202012%20tested%20cord%20blood%20samples%20from%20newly%20delivered%20babies%2C%20the%20CHIKV%20viral%20genome%20was%20detected%20in%206%20%280.3%25%29%20samples%20by%20RT-PCR%2C%20whereas%2C%2015%20samples%20%280.7%25%29%20were%20anti-CHIKV-IgM%20positive.%20Overall%2C%2018%20%280.9%25%2C%2095%25%20CI%3A%200.6%5Cu20131.5%29%20samples%2C%20including%20three%20positives%20for%20both%20CHIKV%20IgM%20and%20viral%20genome%20on%20RT-PCR%2C%20were%20regarded%20as%20vertical%20transmission%20of%20CHIKV%20infection.%20Of%20the%202012%20cord%20blood%20samples%2C%2010%20%280.5%25%2C%2095%25%20CI%3A%200.2%5Cu20130.9%29%20were%20positive%20for%20both%20anti-CHIKV%20IgM%20and%20IgG.%20Twenty-nine%20%281.4%25%2C%2095%25%20CI%3A%201.0%5Cu20132.1%29%20were%20seropositive%20for%20anti-CHIKV%20IgG%20while%2026%20%281.3%25%2C%2095%25%20CI%3A%200.8%5Cu20131.9%29%20of%20them%20were%20also%20positive%20for%20neutralizing%20antibodies%2C%20and%20regarded%20as%20seropositive%20with%20neutralization%20against%20CHIKV%20infection.%5CnConclusion%5CnThis%20is%20the%20first%20report%20of%20a%20possible%20CHIKV%20maternal-neonatal%20infection%20in%20a%20birth%20cohort%20in%20Vietnam.%20The%20findings%20indicate%20that%20follow-up%20and%20a%20differential%20diagnosis%20of%20CHIKV%20infection%20in%20pregnant%20women%20are%20needed%20to%20clarify%20the%20potential%20for%20CHIKV%20vertical%20transmission%20and%20its%20impact%20in%20the%20newborn.%22%2C%22date%22%3A%222024-06-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jiph.2024.04.012%22%2C%22ISSN%22%3A%221876-0341%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1876034124001254%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-06-17T05%3A48%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22EXMPAVZI%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Asakura%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-19%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAsakura%2C%20T.%20R.%2C%20Jung%2C%20S.%2C%20Murayama%2C%20H.%2C%20Ghaznavi%2C%20C.%2C%20Sakamoto%2C%20H.%2C%20Teshima%2C%20A.%2C%20Miura%2C%20F.%2C%20%26amp%3B%20Endo%2C%20A.%20%282024%29.%20%3Ci%3EProjecting%20international%20mpox%20spread%20in%20Asia%3A%20ongoing%20global%20health%20risk%3C%5C%2Fi%3E.%20medRxiv.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.04.17.24305832%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.04.17.24305832%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Projecting%20international%20mpox%20spread%20in%20Asia%3A%20ongoing%20global%20health%20risk%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toshiaki%20R.%22%2C%22lastName%22%3A%22Asakura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sung-mok%22%2C%22lastName%22%3A%22Jung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroaki%22%2C%22lastName%22%3A%22Murayama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cyrus%22%2C%22lastName%22%3A%22Ghaznavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haruka%22%2C%22lastName%22%3A%22Sakamoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayaka%22%2C%22lastName%22%3A%22Teshima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fuminari%22%2C%22lastName%22%3A%22Miura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akira%22%2C%22lastName%22%3A%22Endo%22%7D%5D%2C%22abstractNote%22%3A%22The%20global%20mpox%20outbreak%20affected%20many%20Asian%20countries%20in%202023%2C%20following%20a%20sustained%20local%20transmission%20in%20Japan.%20Given%20the%20large%20population%20sizes%20and%20limited%20vaccine%20rollout%20in%20Asia%2C%20the%20potential%20risk%20of%20global%20mpox%20reemergence%20arising%20from%20Asia%20is%20of%20concern.%20Using%20a%20mathematical%20model%20incorporating%20heterogeneous%20sexual%20networks%20among%20MSM%2C%20calibrated%20to%20incidence%20data%20in%20Japan%2C%20we%20projected%20the%20patterns%20of%20international%20mpox%20spread%20across%2042%20Asian%20countries.%20Our%20simulations%20highlight%20countries%20at%20a%20high%20risk%20of%20mpox%20introductions%2C%20many%20of%20which%20were%20low-%20and%20middle-income%20countries%20%28LMICs%29%20in%20South-eastern%20Asia.%20Our%20analysis%20also%20suggests%20a%20shifting%20focus%20of%20importation%20risk%20from%20Eastern%20Asia%20to%20South-eastern%20Asia%2C%20and%20subsequently%20to%20Central%2C%20Southern%20and%20Western%20Asia%2C%20which%20roughly%20coincided%20with%20the%20observed%20spread%20patterns%20in%202023.%20Global%20cooperation%20and%20support%20are%20warranted%2C%20especially%20for%20LMICs%20with%20an%20elevated%20risk%20of%20mpox%20introduction%2C%20to%20minimise%20the%20risk%20of%20continued%20circulation%20in%20Asia%20and%20beyond.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22medRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222024-04-19%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.04.17.24305832%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.medrxiv.org%5C%2Fcontent%5C%2F10.1101%5C%2F2024.04.17.24305832v1%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-06-17T05%3A46%3A54Z%22%7D%7D%5D%7D
Mogasale, V., Sinha, A., John, J., Farooqui, H., Ray, A., Chantler, T., Mogasale, V., Dhoubhadel, B. G., Edmunds, W. J., Clark, A. D., & Abbas, K. (2024). Typhoid Conjugate Vaccine Implementation in India: A Review of Supportive Evidence (SSRN Scholarly Paper No. 4870785). https://doi.org/10.2139/ssrn.4870785
Ondo, G. N., Ushijima, Y., Abe, H., Mahmoudou, S., Bikangui, R., Nkoma, A. M., Mbadinga, M. J. V. M., More, A., Agbanrin, M. D., Pemba, C. M., Beh Mba, R., Akim, A. A., Lell, B., & Yasuda, J. (2024). Genetic Diversity and Detection of Respiratory Viruses Excluding SARS-CoV-2 during the COVID-19 Pandemic in Gabon, 2020–2021. Viruses, 16(5), 698. https://doi.org/10.3390/v16050698
Murayama, H., Endo, A., & Yonekura, S. (2023). Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics. Epidemics, 45, 100726. https://doi.org/10.1016/j.epidem.2023.100726
Ngwe Tun, M. M., Luvai, E. A. C., Toizumi, M., Moriuchi, M., Takamatsu, Y., Inoue, S., Urano, T., Bui, M. X., Thai Hung, D., Thi Nguyen, H.-A., Anh, D. D., Yoshida, L.-M., Moriuchi, H., & Morita, K. (2024). Possible vertical transmission of Chikungunya virus infection detected in the cord blood samples from a birth cohort in Vietnam. Journal of Infection and Public Health, 17(6), 1050–1056. https://doi.org/10.1016/j.jiph.2024.04.012
Asakura, T. R., Jung, S., Murayama, H., Ghaznavi, C., Sakamoto, H., Teshima, A., Miura, F., & Endo, A. (2024). Projecting international mpox spread in Asia: ongoing global health risk. medRxiv. https://doi.org/10.1101/2024.04.17.24305832
